Dr Ross William Dodge, MD | |
5955 Zeamer Avenue, Jber, AK 99506 | |
(907) 580-3205 | |
Not Available |
Full Name | Dr Ross William Dodge |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 16 Years |
Location | 5955 Zeamer Avenue, Jber, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881850949 | NPI | - | NPPES |
1599973 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 6769 (Alaska) | Primary |
207RS0012X | Internal Medicine - Sleep Medicine | 6769 (Alaska) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Mat-su Regional Medical Center | Palmer, AK | Hospital |
South Peninsula Hospital | Homer, AK | Hospital |
Bartlett Regional Hospital | Juneau, AK | Hospital |
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Mission Hospital Regional Med Center | Mission viejo, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peak Neurology And Sleep Medicine, Llc | 6901024017 | 10 |
News Archive
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder in the U.S.
Insurers and pharmaceutical manufacturers are concerned that changes in a Senate bill could derail efforts — and their agreement — to overhaul the nation's health care system.
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.
› Verified 5 days ago
Entity Name | South Peninsula Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679566269 PECOS PAC ID: 5395636930 Enrollment ID: O20040323000583 |
News Archive
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder in the U.S.
Insurers and pharmaceutical manufacturers are concerned that changes in a Senate bill could derail efforts — and their agreement — to overhaul the nation's health care system.
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.
› Verified 5 days ago
Entity Name | Peak Neurology And Sleep Medicine, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194130823 PECOS PAC ID: 6901024017 Enrollment ID: O20140903001689 |
News Archive
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder in the U.S.
Insurers and pharmaceutical manufacturers are concerned that changes in a Senate bill could derail efforts — and their agreement — to overhaul the nation's health care system.
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ross William Dodge, MD 5955 Zeamer Avenue, Jber, AK 99506 Ph: () - | Dr Ross William Dodge, MD 5955 Zeamer Avenue, Jber, AK 99506 Ph: (907) 580-3205 |
News Archive
A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.
Ohio, West Virginia, and the District of Columbia have the highest disparity between opioid-related deaths and access to treatment providers for opioid use disorder in the U.S.
Insurers and pharmaceutical manufacturers are concerned that changes in a Senate bill could derail efforts — and their agreement — to overhaul the nation's health care system.
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration ("FDA") to begin a prospective, multicenter, randomized clinical trial for its lead product, TissuGlu Surgical Adhesive in the United States.
› Verified 5 days ago
Colleen Kersgard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-3130 | |
Dr. Jason Hunt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2778 | |
Dr. James Warren Freese, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Avenue, 673d Mdg, Jber, AK 99506 Phone: 907-580-4118 | |
Joshua Einar Erlandsen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 673 Mdg, 5955 Zeamer Avenue, Jber, AK 99506 Phone: 907-580-2506 Fax: 907-580-2505 | |
Dr. Jonathan Coyle, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2732 Fax: 907-580-3203 | |
Dr. Joshua W Donart, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2506 | |
Dr. Roy S. Norris, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Ave, Jber, AK 99506 Phone: 907-580-2778 |